You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 1 - 10 of 8750 results
  1. Dual Fatty Acid Amide Hydrolase (FAAH)/Monoacylglycerol lipase (MAGL) Inhibitors for Cannabis Use Disorder (CUD).

    SBC: MAKSCIENTIFIC            Topic: NIDA

    OTHER PROJECT INFORMATION – Unit 7 – Project Summary/Abstract This project addresses the growing need for medications for cannabis use disorder (CUD) which, in the absence of approved medications, is a major focus of NIDA’s mission. Currently available cannabinergic-based treatments for CUD include the directly acting CB1 agonists, e.g., Δ9-THC or nabilone, which have been reported to reduc ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  2. Field Instrument for Assessment of Arsenic Exposure

    SBC: GINER INC            Topic: R

    Project Summary Human exposure to toxic heavy metals existing in drinking water, food, and the environment is an area of increasing national and international concern. Heavy metals are significant environmental pollutants because they tend to persist, bioaccumulate and can result in serious adverse acute or chronic health effects after ingested or inhaled. Traditionally, trace metals are measured ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  3. An innovative telomerase-targeted, circulating tumor cell assay for monitoring NSCLC treated with radiation and immunotherapy

    SBC: Liquid Biotech USA, Inc.            Topic: 102

    Project Summary: Cancer is a leading cause of death both in the United States and across the world, claiming over 600,000 and 8 million deaths each year, respectively. Delayed detection of cancer progression or recurrence after treatment contributes to increased morbidity and rapid death, but re-biopsy or repeat surgery is usually not possible due to severe risks. The accuracy of conventional imag ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  4. Preclinical Evaluation of a Novel Immunomodulatory Vaccine for Preventing and Treating HSV Infections

    SBC: Rational Vaccines, Inc.            Topic: NIAID

    PROJECT SUMMARY: Herpes Simplex Virus (HSV) infections are common, infecting more than half of the world’s population. While most cases of genital herpes are caused by HSV type 2 (HSV-2), it is estimated that more than 150 million people aged 15-49 have genital HSV type 1 (HSV-1) infections. Although several vaccines have been evaluated for preventing/treating HSV infections, none have received ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  5. Preclinical validation of small molecule immunomodulators for the treatment of Crohn's disease

    SBC: PROMAKHOS THERAPEUTICS INC            Topic: 300

    Project Summary Crohn’s disease is a debilitating and chronic inflammatory disorder of the gastrointestinal tract characterized by aberrant healing and intestinal stricturing. In the US, rt500,000 patients suffer from Crohn’s disease and over 30,000 patients are newly diagnosed each year. No curative treatments exist. Instead, current treatments focus on managing symptoms and reducing the occu ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  6. Noregen, a regenerative medicine ocular therapeutic

    SBC: Retinal Solutions LLC            Topic: NEI

    ABSTRACT Ischemic retinopathies, such as diabetic retinopathy and retinal vein occlusion, are the leading cause of blindness in the United States. Common features are leaky vessels, swelling, capillary drop out, aberrant vessel growth and retinal detachment. Current treatments include laser ablation, anti-VEGFs and steroids. All are sub-optimal and only serve to slow disease progression and vision ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  7. T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy

    SBC: ABBRATECH INC.            Topic: 300

    ABSTRACT Current therapeutic antibodies target the cell surface and within the external cellular environment. Yet intracellular proteins make up half of the proteome. Having a facile means of targeting those intracellular proteins for the generation of therapeutic antibodies would be highly desirable. Targeting MHC complexed with neoantigens from intracellular proteins would greatly allow the gene ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  8. Development of an empathetic chatbot to monitor perinatal mental health longitudinally

    SBC: Poisera, Inc.            Topic: 104

    1 ABSTRACT2 One in five pre- or postnatal women will develop a perinatal mood disorder (PMD). While temporary and3 treatable, 50-65% of mothers with PMD symptoms never receive a diagnosis or treatment due to inadequate4 screening practices. PMDs remain undetected because mothers do not trust clinicians due to fear of judgment,5 stigma, or even loss of parental rights. Untreated PMDs increase risk ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  9. Improved optimization of covalent ligands using a novel implementation of quantum mechanics suitable for large ligand/protein systems.

    SBC: QUANTUM SIMULATION TECHNOLOGIES INC            Topic: 400

    Project Summary The value of computational chemistry to commercial drug discovery is now well-established. Virtual screening (including molecular docking) now jumpstarts most discovery efforts. Tools such as molecular dynamics and free energy perturbation are increasingly used to inform the later stages of lead refinement. The growing importance of computational structure-based methods has influen ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  10. A Novel Synthetic Biology-Derived Microbiome Therapeutic to Treat Viral-Induced Acute Respiratory Distress Syndrome (ARDS)

    SBC: Rise Therapeutics, LLC            Topic: NIAID

    PROJECT SUMMARY Acute respiratory distress syndrome (ARDS) is a severe life-threatening complication that can be caused by viral infection. The disease is characterized by cytokine-driven hyperinflammation and leukocytes count changes. The innate immune response has been linked to ARDS immunopathogenesis. In this regard, neutrophils have been highlighted as essential effector cells in the developm ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government